Work Here?
T45 Labs
Work Here?
Develops acquisition-ready cardiovascular medtech startups
T45 Labs
Work Here?
Develops acquisition-ready cardiovascular medtech startups
Overview
T45 Labs is a Silicon Valley medtech incubator and investment platform that builds acquisition-ready cardiovascular companies. It reduces development risk by guiding technologies through key clinical and regulatory milestones and by refining concepts in validated markets using a best-follower approach. Through T45 Fund-I and T45 Fund-II, it partners with physicians and entrepreneurs to create differentiated cardiovascular startups with clear paths to strategic acquisition and investor returns. The goal is to deliver cardiovascular companies that meet milestones and are attractive exits for strategic buyers and investors.
About T45 Labs
Industries
Venture Capital
Healthcare
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Moose, Wyoming
Founded
2022
Get referred to T45 Labs
See people who can refer or advise you
Simplify's Take
What believers are saying
- T45 Labs closed an oversubscribed $25 million Fund I on March 19, 2025.
- Advanced NanoTherapies raised $31 million in June 2026 and advanced to U.S. pivotal planning.
- VahatiCor enrolled its first U.S. patient on June 17, 2026, validating clinical traction.
What critics are saying
- T45 Labs depends on portfolio exits; no durable revenues exist outside financing rounds.
- ANT and VahatiCor still face FDA, trial, and manufacturing execution risk through 2026.
- A failed pivotal or reimbursement path in cardiovascular devices would collapse T45 Labs' strategy.
What makes T45 Labs unique
- T45 Labs builds and funds cardiovascular medtech through a Silicon Valley incubator model.
- Its 25,000-square-foot facility and clinician network speed device iteration and commercialization.
- Portfolio assets span multiple shots on goal, including ANT, VahatiCor, NuevoSono, and ReCava.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company Equity
Performance Bonus
Growth & Insights and Company News
6 month growth
↑ 20%1 year growth
↑ 20%2 year growth
↑ 33%T45 Labs, a specialized medical technology innovation company focused on accelerating the development of cardiovascular solutions for large and underserved markets, today announced the successful close of its $25 million T45 Fund I. The oversubscribed fund demonstrates strong investor confidence in T45 Labs' mission to deliver breakthrough cardiovascular technologies that drive meaningful advancements in patient care.
T45 Labs announced the successful close of its oversubscribed $25M T45 Fund I to advance cardiovascular medical device development. The fund will support clinical research and milestone achievements for portfolio companies, including Advanced NanoTherapies, Vahaticor, NuevoSono, and ReCava. Located in a 25,000 sq. ft. facility in Silicon Valley, T45 Labs collaborates with clinicians to innovate and commercialize devices.
T45 Labs is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
About T45 Labs
Industries
Venture Capital
Healthcare
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Moose, Wyoming
Founded
2022
T45 Labs is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today